Journal article · 2025 · Open access
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia
European Psychiatry, 68(S1), S70 · Published 1 April 2025 · DOI 10.1192/j.eurpsy.2025.210
In brief
“Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia” is a 2025 journal article by Armida Mucci, published in European Psychiatry. OpenAlex counts 0 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at European Psychiatry.
- Citations
- 0
- Authors
- 1
Abstract
The presentation will summarize recent findings on the role of the two domains of negative symptoms (motivational impairment and expressive impairment) and social cognition as mediators of the impact of neurocognitive impairment on functional outcomes in people living with schizophrenia (PLWS). One hundred and fifty subjects from 8 different European centers were recruited. Our data showed that the expressive impairment predicted global functioning and together with motivational impairment fully mediated the effects of neurocognition on the same outcome. Motivational impairment was a predictor of personal and social functioning and fully mediated neurocognitive impairment effects on the same outcome. Both motivational and neurocognitive impairments predicted socially useful activities, and the emotion recognition domain of social cognition partially mediated the impact of neurocognitive deficits on this outcome. Our results indicate that pathways to functional outcomes are specific for different domains of real-life functioning and that negative symptoms and social cognition mediate the impact of neurocognitive impairment on different domains of functioning. Our results suggest that psychosocial interventions should target both negative symptoms and social cognition to enhance the functional impact of cognitive remediation. Disclosure of Interest A. Mucci Consultant of: Angelini, Gedeon Richter Bulgaria, Janssen Pharmaceuticals, Lundbeck, Otsuka Pharmaceutical, Pfizer, Pierre Fabre, Rovi Pharma and Boehringer Ingelheim.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Mucci, A. (2025). Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia. European Psychiatry, 68(S1), S70. https://doi.org/10.1192/j.eurpsy.2025.210
MLA 9
Mucci, Armida. “Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia.” European Psychiatry, vol. 68, no. S1, 2025, p. S70. https://doi.org/10.1192/j.eurpsy.2025.210.
Chicago
Mucci, Armida. 2025. “Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia.” European Psychiatry 68 (S1): S70. https://doi.org/10.1192/j.eurpsy.2025.210.
Harvard
Mucci, A. (2025) ‘Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia’, European Psychiatry, 68(S1), p. S70. doi:10.1192/j.eurpsy.2025.210.
IEEE
A. Mucci, “Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia,” European Psychiatry, vol. 68, no. S1, p. S70, 2025, doi: 10.1192/j.eurpsy.2025.210.
BibTeX
@article{mucci2025negative,
title = {{Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia}},
author = {Mucci, Armida},
journal = {European Psychiatry},
year = {2025},
volume = {68},
number = {S1},
pages = {S70},
doi = {10.1192/j.eurpsy.2025.210},
url = {https://doi.org/10.1192/j.eurpsy.2025.210}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- social cognition
- neurocognitive impairment
- functional outcome
- motivational impairment
- mediation analysis
- emotion recognition
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Mucci, A. (2025). Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia. European Psychiatry, 68(S1), S70. https://doi.org/10.1192/j.eurpsy.2025.210
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at European Psychiatry: sign in and open the PDF from this page.
Who wrote this paper?
Armida Mucci.
What is the DOI of this paper?
10.1192/j.eurpsy.2025.210, permanently at https://doi.org/10.1192/j.eurpsy.2025.210. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.